In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate
Carlo Tascini(Ospedale D. Cotugno), Francesco Menichetti(Azienda Ospedaliera Universitaria Pisana), Simone Ferranti(Azienda Ospedaliera Universitaria Pisana), Fernando Messina(Hospital Muñiz)
Cited by 34
Related Papers
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Added Value of <sup>99m</sup>Tc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis
|Journal of Nuclear Medicine|2012|221
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria
|Intensive Care Medicine|2015|182